 NEW YORK, NY ACCESSWIRE July 15, 2020 Pomerantz LLP is investigating claims on behalf of investors of MEI Pharma, Inc. MEI Pharma or the Company MEIP. Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. The investigation concerns whether MEI Pharma and certain of its officers andor directors have engaged in securities fraud or other unlawful business practices. 